Amedes
GermanyWho owns Amedes?
Amedes is a German MedTech company, now owned by OMERS / Goldman Sachs / AXA IM, which acquired it in 2021 from Antin Infrastructure Partners.
General Atlantic is still listed as an investor in Amedes, status not confirmed after the 2021 sale.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods
Antin Infrastructure Partners sold Amedes to OMERS / Goldman Sachs / AXA IM in 2021 after 6 years.
More from General Atlantic
Other portfolio companies in the same fund.
US
UKMore PE-backed in MedTech
Comparable medtech deals from other GPs.
Questions
Who owns Amedes?
Amedes is now owned by OMERS / Goldman Sachs / AXA IM, which acquired it in 2021 from Antin Infrastructure Partners. General Atlantic is still listed as an investor in Amedes, status not confirmed after the 2021 sale.
When did OMERS / Goldman Sachs / AXA IM acquire Amedes?
OMERS / Goldman Sachs / AXA IM acquired Amedes in 2021, buying from Antin Infrastructure Partners.
Who did Amedes sell to?
Antin Infrastructure Partners sold Amedes to OMERS / Goldman Sachs / AXA IM in 2021 (Secondary).
Who has owned Amedes over time?
Amedes has been through 2 private-equity ownership periods: Antin Infrastructure Partners · via Antin Infrastructure Partners Fund II · 2015–2021 · sold to OMERS / Goldman Sachs / AXA IM · (Secondary); General Atlantic · via General Atlantic.